Love Pharma moves to buy transdermal opioid-use disorder player

[cafead]

via Love Pharma has struck a deal to acquire transdermal drug delivery technology, signing a letter of intent to buy Naltrexone Therapeutics for intellectual property covering the administration of a treatment of alcohol and opioid-use disorder.

article source